What I meant was, the cost, including amortization of fixed costs, is still legitimately high (and thus would be expensive for very different reasons from the typical "health care WTF" -- and most health care spending isn't in the form of pharmaceuticals). And expecting high-fixed-cost goods to be priced based on the marginal unit ... is the wrong heuristic to begin with.